CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Israeli arms maker and Dutch defence company to start weapons production in Netherlands

By Reuters News

AMSTERDAM, Nov 9 (Reuters) - Israeli firearms maker Israel Weapon Industries (IWI) and Dutch defence company Artillerie Inrichtingen Armaments (AIA) plan to manufacture and assemble IWI weapon systems in the Netherlands, the companies said on Monday.

  • IWI will start to manufacture and assemble the ARAD 5 rifle and the NEGEV UX in a factory in the Netherlands

  • IWI will provide the underlying technology, product expertise and manufacturing know-how

  • AIA will establish the Dutch manufacturing operation and infrastructure to deliver and support the products

  • Assembly will start at AIA's site in Tilburg, with the possibility of moving to a different location in the near future, the companies said

  • Production will be phased, starting with assembly, followed by partial production in the Netherlands and eventually full domestic production, AIA said, without giving specific timeframes or investment figures

  • IWI is part of SK Group and is the main supplier to the Israeli Army and Israeli Police

  • "The Netherlands needs the ability to manufacture, develop expertise and support the defence systems on which its security depends," AIA Chief Executive Gerard Zondervan said in a statement

  • AIA said the Dutch government was not involved in the agreement

  • The Dutch Defence Ministry did not immediately reply to a request for comment

  • On Sunday, protesters in Amsterdam called on the Dutch government to take a tougher stance against Israel over its actions in the Palestinian territories. Organisers said the protest drew 200,000 participants

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.